MindBio to List on CSE

MindBio Therapeutics announces spin out listing from Blackhawk.

We are pleased to announce that MindBio has begun preparations to spin out from Blackhawk and on the Canadian Securities Exchange as a separate entity. Investors in Blackhawk will receive a 1:1 share in MindBio at the record date.

Market Announcement excerpt:

Vancouver, British Columbia – December 15, 2021 – Blackhawk Growth Corp. (CSE:BLR; Frankfurt:0JJ) ( “Blackhawk”), is pleased to announce that it intends to undertake a spin-out transaction whereby the shares of its wholly owned subsidiaries MindBio Therapeutics Pty. Ltd. and Digital Mind Technology Pty Ltd. will form an independent company to focus solely on the psychedelics business. As part of the spinout process, a new subsidiary of Blackhawk (“SpinCo”) will be created, which will hold all of the above-named subsidiaries. SpinCo is to be renamed MindBio Therapeutics Corp. MindBio Therapeutics Corp. will be an independent public company focused on the psychedelic sector and mental health therapies. All shareholders of Blackhawk will receive one common share in MindBio Therapeutics Corp. for every share held in Blackhawk, on a pro rata basis, based on a record date that is expected to be set in early 2022.

Read full Market Announcement here.